- November 30, 2023- Notice of Change: Extension of PAR-22-028 "Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)" by one Council Round. See Notice NOT-NS-24-035.
- November 9, 2021 - Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional). See NOFO PAR-22-030.
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of an extension to PAR-22-030"Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)". The NOFO will be extended by one additional council round. Due to the extension, the following dates have been added: New, Resubmission, Revision due date: October 10, 2024. Expiration date October 11, 2024. Changes to the NOFO are shown below.
Currently Reads:
Part 1. Overview Information
Key Dates
Application Due Dates | Review and Award Cycles | ||||
New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| December 22, 2021 | December 22, 2021 | Not Applicable | March 2022 | May 2022 | July 2022 |
| February 09, 2022 | February 09, 2022 | Not Applicable | July 2022 | October 2022 | December 2022 |
| June 09, 2022 | June 09, 2022 | Not Applicable | November 2022 | January 2023 | April 2023 |
| October 08, 2022 | October 08, 2022 | Not Applicable | March 2023 | May 2023 | July 2023 |
| February 09, 2023 | February 09, 2023 | Not Applicable | July 2023 | October 2023 | December 2023 |
| June 09, 2023 | June 09, 2023 | Not Applicable | November 2023 | January 2024 | April 2024 |
| October 10, 2023 | October 10, 2023 | Not Applicable | March 2024 | May 2024 | July 2024 |
| February 08, 2024 | February 08, 2024 | Not Applicable | July 2024 | October 2024 | December 2024 |
| June 07, 2024 | June 07, 2024 | Not Applicable | November 2024 | January 2025 | April 2025 |
Expiration Date: June 8, 2024
Modified to Read:
Part 1. Overview Information
Key Dates
Application Due Dates | Review and Award Cycles | ||||
New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| December 22, 2021 | December 22, 2021 | Not Applicable | March 2022 | May 2022 | July 2022 |
| February 09, 2022 | February 09, 2022 | Not Applicable | July 2022 | October 2022 | December 2022 |
| June 09, 2022 | June 09, 2022 | Not Applicable | November 2022 | January 2023 | April 2023 |
| October 08, 2022 | October 08, 2022 | Not Applicable | March 2023 | May 2023 | July 2023 |
| February 09, 2023 | February 09, 2023 | Not Applicable | July 2023 | October 2023 | December 2023 |
| June 09, 2023 | June 09, 2023 | Not Applicable | November 2023 | January 2024 | April 2024 |
| October 10, 2023 | October 10, 2023 | Not Applicable | March 2024 | May 2024 | July 2024 |
| February 08, 2024 | February 08, 2024 | Not Applicable | July 2024 | October 2024 | December 2024 |
| June 07, 2024 | June 07, 2024 | Not Applicable | November 2024 | January 2025 | April 2025 |
| October 10, 2024 | October 10, 2024 | Not Applicable | March 2025 | May 2025 | July 2025 |
Expiration Date: October 11, 2024
All other aspects of this NOFO remain unchanged.
Chris Boshoff, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: chris.boshoff@nih.gov
and Human Services (HHS)
